{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T17:05:37Z","timestamp":1791565537483,"version":"4.3.4"},"reference-count":205,"publisher":"Tech Science Press","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["OR"],"published-print":{"date-parts":[[2025]]},"DOI":"10.32604\/or.2025.062197","type":"journal-article","created":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T04:47:12Z","timestamp":1745556432000},"page":"1547-1570","source":"Crossref","is-referenced-by-count":15,"title":["Unlocking the potential of tumor-targeting peptides in precision oncology"],"prefix":"10.32604","volume":"33","author":[{"given":"HAFIZ MUHAMMAD","family":"REHMAN","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SIDRA","family":"AHMAD","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"AZEEM","family":"SARWAR","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"HAMID","family":"BASHIR","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"17807","published-online":{"date-parts":[[2025]]},"reference":[{"key":"ref1","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1016\/j.gendis.2022.02.007","article-title":"Cancer chemotherapy and beyond: current status, drug candidates, associated risks and progress in targeted therapeutics","volume":"10","author":"Anand","year":"2023","journal-title":"Genes Dis"},{"key":"ref3","unstructured":"DeVita VTJr, Rosenberg SA, Lawrence TS. DeVita, Hellman, and Rosenberg\u2019s cancer: short title: Lippincott Williams & Wilkins; 2022 [cited 2025 Feb 10]. Available from: https:\/\/dl.mehrsys.ir\/pdfbooks\/DeVita,%20Hellman,%20and%20Rosenberg_s%20Cancer%20Principles%20&%20Practice%20of%20Oncology%2010th%20Edition(www.myuptodate.com).pdf."},{"key":"ref4","doi-asserted-by":"crossref","first-page":"296","DOI":"10.62940\/als.v11i2.3106","article-title":"Current advances on single or multi-omics analysis of esophageal cancer","volume":"11","author":"Kasimu","year":"2024","journal-title":"Adv Life Sci"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.3390\/cancers16132478","article-title":"Emerging therapeutic strategies to overcome drug resistance in cancer cells","volume":"16","author":"Garg","year":"2024","journal-title":"Cancers"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.1200\/JCO.2003.01.504","article-title":"Status of epidermal growth factor receptor antagonists in the biology and treatment of cancer","volume":"21","author":"Mendelsohn","year":"2003","journal-title":"J Clin Oncol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"109979","DOI":"10.1016\/j.isci.2024.109979","article-title":"Hallmarks of cancer resistance","volume":"27","author":"Tufail","year":"2024","journal-title":"iScience"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"7138","DOI":"10.15419\/bmrat.v12i2.959","article-title":"Computational design and evaluation of a novel temporin 1CEa-IL24 fusion protein for anti-tumor potential","volume":"12","author":"Rehman","year":"2025","journal-title":"Biomed Res Ther"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/s41573-020-00135-8","article-title":"Trends in peptide drug discovery","volume":"20","author":"Muttenthaler","year":"2021","journal-title":"Nat Rev Drug Discov"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/nm0596-561","article-title":"Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells","volume":"2","author":"Druker","year":"1996","journal-title":"Nat Med"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s43556-024-00210-1","article-title":"Monoclonal antibodies: from magic bullet to precision weapon","volume":"5","author":"Aboul-Ella","year":"2024","journal-title":"Mol Biomed"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/s41573-022-00579-0","article-title":"Targeting HER2-positive breast cancer: advances and future directions","volume":"22","author":"Swain","year":"2023","journal-title":"Nat Rev Drug Discov"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"35","DOI":"10.62940\/als.v12i1.3334","article-title":"Understanding the role of genetics in tumour and cancer biology","volume":"12","author":"Asiri","year":"2025","journal-title":"Advan Life Sci"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1804038","DOI":"10.1155\/2024\/1804038","article-title":"The potential of single-chain variable fragment antibody: role in future therapeutic and diagnostic biologics","volume":"2024","author":"Gezehagn Kussia","year":"2024","journal-title":"J Immunol Res"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1038\/nrd3229","article-title":"Development trends for human monoclonal antibody therapeutics","volume":"9","author":"Nelson","year":"2010","journal-title":"Nat Rev Drug Discov"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1186\/s12951-024-02900-y","article-title":"Discovery of nanobodies: a comprehensive review of their applications and potential over the past five years","volume":"22","author":"Alexander","year":"2024","journal-title":"J Nanobiotechnol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"321","DOI":"10.21037\/atm-22-3882","article-title":"A new era of gene and cell therapy for cancer: a narrative review","volume":"11","author":"Wang","year":"2023","journal-title":"Ann Transl Med"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"15688","DOI":"10.3390\/ijms242115688","article-title":"CAR-T cell therapy: from the shop to Cancer therapy","volume":"24","author":"Uscanga-Palomeque","year":"2023","journal-title":"Int J Mol Sci"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"340319","DOI":"10.1016\/j.aca.2022.340319","article-title":"A review: development and application of surface molecularly imprinted polymers toward amino acids, peptides, and proteins","volume":"1234","author":"Zhang","year":"2022","journal-title":"Anal Chim Acta"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"103464","DOI":"10.1016\/j.drudis.2022.103464","article-title":"Peptide-based drug discovery: current status and recent advances","volume":"28","author":"Sharma","year":"2023","journal-title":"Drug Discov Today"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"7842","DOI":"10.3390\/ijms24097842","article-title":"Targeting protein-protein interfaces with peptides: the contribution of chemical combinatorial peptide library approaches","volume":"24","author":"Monti","year":"2023","journal-title":"Int J Mol Sci"},{"key":"ref22","first-page":"268","article-title":"Peptide-based nanomaterials: self-assembly, properties and applications","volume":"11","author":"Li","year":"2022","journal-title":"Bioact Mater"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"728","DOI":"10.3390\/polym16060728","article-title":"Anticancer potential of antimicrobial peptides: focus on buforins","volume":"16","author":"Tolos","year":"2024","journal-title":"Polym"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"824989","DOI":"10.3389\/fmolb.2022.824989","article-title":"Mastoparans: a group of multifunctional \u03b1-helical peptides with promising therapeutic properties","volume":"9","author":"de Santana","year":"2022","journal-title":"Front Mol Biosci"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.eururo.2005.12.043","article-title":"Antitumor activity of the antimicrobial peptide magainin II against bladder cancer cell lines","volume":"50","author":"Lehmann","year":"2006","journal-title":"Eur Urol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"5330","DOI":"10.1046\/j.1432-1327.2000.01536.x","article-title":"The antibiotic and anticancer active aurein peptides from the Australian Bell Frogs Litoria aurea and Litoria raniformis: the solution structure of aurein 1.2","volume":"267","author":"Rozek","year":"2000","journal-title":"Eur J Biochem"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"294","DOI":"10.3389\/fmicb.2013.00294","article-title":"From antimicrobial to anticancer peptides. A review","volume":"4","author":"Gaspar","year":"2013","journal-title":"Front Microbiol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"9032","DOI":"10.1080\/10408398.2023.2207650","article-title":"Lactoferricin, an antimicrobial motif derived from lactoferrin with food preservation potential","volume":"64","author":"Wu","year":"2024","journal-title":"Crit Rev Food Sci Nutr"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"200004","DOI":"10.1098\/rsob.200004","article-title":"Anti-cancer peptides: classification, mechanism of action, reconstruction and modification","volume":"10","author":"Xie","year":"2020","journal-title":"Open Biol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.2174\/0109298673253414231127162817","article-title":"Bacterial proteins and peptides as potential anticancer agents: a novel search for protein-based therapeutics","volume":"32","author":"Pyla","year":"2024","journal-title":"Curr Med Chem"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s00897000455a","article-title":"Lehninger principles of biochemistry; by David L. Nelson and Michael M. Cox","volume":"6","author":"Fisher","year":"2001","journal-title":"Chem Educator"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1080\/17425247.2022.2094363","article-title":"Phage in cancer treatment\u2014biology of therapeutic phage and screening of tumor targeting peptide","volume":"19","author":"Manivannan","year":"2022","journal-title":"Expert Opin Drug Deliv"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"8554","DOI":"10.3390\/ijms23158554","article-title":"The screening of therapeutic peptides for anti-inflammation through phage display technology","volume":"23","author":"Zhang","year":"2022","journal-title":"Int J Mol Sci"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1039\/D0LC01146K","article-title":"Highly paralleled emulsion droplets for efficient isolation, amplification, and screening of cancer biomarker binding phages","volume":"21","author":"Wang","year":"2021","journal-title":"Lab Chip"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"123077","DOI":"10.1016\/j.lfs.2024.123077","article-title":"Phage display screening in breast cancer: from peptide discovery to clinical applications","volume":"357","author":"Ning","year":"2024","journal-title":"Life Sci"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"481","DOI":"10.3390\/pharmaceutics13040481","article-title":"Peptide-based strategies for targeted tumor treatment and imaging","volume":"13","author":"Ayo","year":"2021","journal-title":"Pharmaceutics"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/17460441.2024.2367023","article-title":"Phage display technology and its impact in the discovery of novel protein-based drugs","volume":"19","author":"Hutchings","year":"2024","journal-title":"Expert Opin Drug Discov"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/nbt0697-553","article-title":"Yeast surface display for screening combinatorial polypeptide libraries","volume":"15","author":"Boder","year":"1997","journal-title":"Nat Biotechnol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"108422","DOI":"10.1016\/j.biotechadv.2024.108422","article-title":"Yeast surface display technology: mechanisms, applications, and perspectives","volume":"76","author":"Li","year":"2024","journal-title":"Biotechnol Adv"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.abb.2012.03.009","article-title":"Engineering antibodies by yeast display","volume":"526","author":"Boder","year":"2012","journal-title":"Arch Biochem Biophys"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/978-1-4939-2748-7_8","article-title":"Applications of yeast surface display for protein engineering","volume":"1319","author":"Cherf","year":"2015","journal-title":"Yeast Surface Display: Methods Protoc Appl"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"E6506","DOI":"10.1073\/pnas.1519623112","article-title":"Engineering high-affinity PD-1 variants for optimized immunotherapy and immuno-PET imaging","volume":"112","author":"Maute","year":"2015","journal-title":"Proc Natl Acad Sci"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"794742","DOI":"10.3389\/fbioe.2021.794742","article-title":"Yeast surface display system: strategies for improvement and biotechnological applications","volume":"9","author":"Teymennet-Ram\u00edrez","year":"2022","journal-title":"Front Bioeng Biotechnol"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1002\/cmdc.202000869","article-title":"Scanning protein surfaces with DNA-encoded libraries","volume":"16","author":"Kunig","year":"2021","journal-title":"ChemMedChem"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"110","DOI":"10.2174\/1872208317666230512143508","article-title":"Fundamental uses of peptides as a new model in both treatment and diagnosis","volume":"18","author":"Okasha","year":"2024","journal-title":"Recent Pat Biotechnol"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.addr.2016.05.009","article-title":"Tumor-targeting peptides from combinatorial libraries","volume":"110","author":"Liu","year":"2017","journal-title":"Adv Drug Deliv Rev"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"108559","DOI":"10.1016\/j.pharmthera.2023.108559","article-title":"From exploring cancer and virus targets to discovering active peptides through mRNA display","volume":"252","author":"Brango-Vanegas","year":"2023","journal-title":"Pharmacol Ther"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s11658-022-00332-w","article-title":"Anti-cancer peptide-based therapeutic strategies in solid tumors","volume":"27","author":"Karami Fath","year":"2022","journal-title":"Cell Mol Biol Lett"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.3390\/md10081852","volume":"10","author":"Wu","year":"2012","journal-title":"Mar Drugs"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"2850","DOI":"10.1158\/1538-7445.AM2012-2850","article-title":"Demonstration of anti-tumor efficacy in multiple preclinical cancer models using a novel peptide inhibitor (Aurigene-012) of the PD1 signaling pathway","volume":"72","author":"Sasikumar","year":"2012","journal-title":"Cancer Res"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"144","DOI":"10.3390\/toxins8050144","volume":"8","author":"Shi","year":"2016","journal-title":"Toxins"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s00203-016-1206-8","volume":"198","author":"Li","year":"2016","journal-title":"Arch Microbiol"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"17158","DOI":"10.1021\/acsami.1c03640","article-title":"Delivery strategies for melittin-based cancer therapy","volume":"13","author":"Zhou","year":"2021","journal-title":"ACS Appl Mater Interfaces"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s00726-009-0384-y","volume":"40","author":"Lib\u00e9rio","year":"2011","journal-title":"Amino Acids"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"5052","DOI":"10.1073\/pnas.1202653110","article-title":"Cod glycopeptide with picomolar affinity to galectin-3 suppresses T-cell apoptosis and prostate cancer metastasis","volume":"110","author":"Guha","year":"2013","journal-title":"Proc Natl Acad Sci"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1007\/s10930-016-9662-1","volume":"35","author":"Theansungnoen","year":"2016","journal-title":"Protein J"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"153","DOI":"10.3390\/md14080153","volume":"14","author":"Pan","year":"2016","journal-title":"Mar Drugs"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1139\/bcb-2016-0175","article-title":"Anticancer activities of bovine and human lactoferricin-derived peptides","volume":"95","author":"Arias","year":"2017","journal-title":"Biochem Cell Biol"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"113712","DOI":"10.1016\/j.ejmech.2021.113712","article-title":"Source and exploration of the peptides used to construct peptide-drug conjugates","volume":"224","author":"Zhou","year":"2021","journal-title":"Eur J Med Chem"},{"key":"ref60","first-page":"435","article-title":"Advance of several types of important marine antitumor drugs","volume":"43","author":"Zhang","year":"2008","journal-title":"Yao Xue Xue Bao = Acta Pharmaceutica Sinica"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.foodchem.2014.02.050","article-title":"Peptides in common bean fractions inhibit human colorectal cancer cells","volume":"157","author":"Vital","year":"2014","journal-title":"Food Chem"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.foodres.2015.09.027","volume":"77","author":"Xue","year":"2015","journal-title":"Food Res Int"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1039\/C6FO00042H","volume":"7","author":"Wang","year":"2016","journal-title":"Food Funct"},{"key":"ref64","first-page":"285","author":"Saha","year":"2024","journal-title":"Seeds: anti-proliferative storehouse for bioactive secondary metabolites"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.jff.2017.12.062","volume":"42","author":"V\u00e1squez-Villanueva","year":"2018","journal-title":"J Funct Foods"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"5201","DOI":"10.3390\/ijms11125201","article-title":"Anti-tumor activity of a novel protein obtained from tartary buckwheat","volume":"11","author":"Guo","year":"2010","journal-title":"Int J Mol Sci"},{"key":"ref67","doi-asserted-by":"crossref","first-page":"7453","DOI":"10.3390\/molecules26247453","article-title":"Natural peptides inducing cancer cell death: mechanisms and properties of specific candidates for cancer therapeutics","volume":"26","author":"Trinidad-Calder\u00f3n","year":"2021","journal-title":"Molecules"},{"key":"ref68","doi-asserted-by":"crossref","first-page":"9548","DOI":"10.3390\/ijms23179548","article-title":"Lunasin as a promising plant-derived peptide for cancer therapy","volume":"23","author":"Alves de Souza","year":"2022","journal-title":"Int J Mol Sci"},{"key":"ref69","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.bionut.2014.04.006","volume":"4","author":"Umayaparvathi","year":"2014","journal-title":"Biomed Prev Nutr"},{"key":"ref70","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1080\/01635581.2017.1295087","article-title":"Antiproliferative activity of egg yolk peptides in human colon cancer cells","volume":"69","author":"Yousr","year":"2017","journal-title":"Nutr Cancer"},{"key":"ref71","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12885-016-2281-6","article-title":"The milk-derived fusion peptide, ACFP, suppresses the growth of primary human ovarian cancer cells by regulating apoptotic gene expression and signaling pathways","volume":"16","author":"Zhou","year":"2016","journal-title":"BMC Cancer"},{"key":"ref72","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1016\/j.bbrc.2008.10.166","article-title":"A novel integrin \u03b15\u03b21 antagonistic peptide, A5-1, screened by protein chip system as a potent angiogenesis inhibitor","volume":"377","author":"Kim","year":"2008","journal-title":"Biochem Biophys Res Commun"},{"key":"ref73","doi-asserted-by":"crossref","first-page":"6697","DOI":"10.3892\/mmr.2017.7418","volume":"16","author":"Huang","year":"2017","journal-title":"Mol Med Rep"},{"key":"ref74","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jdermsci.2009.06.016","volume":"56","author":"Castro","year":"2009","journal-title":"J Dermatol Sci"},{"key":"ref75","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.21873\/invivo.11356","article-title":"Antitumor ability of KT2 peptide derived from leukocyte peptide of crocodile against human HCT116 colon cancer xenografts","volume":"32","author":"Maraming","year":"2018","journal-title":"Vivo"},{"key":"ref76","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.7150\/thno.14302","article-title":"HER2 targeting peptides screening and applications in tumor imaging and drug delivery","volume":"6","author":"Geng","year":"2016","journal-title":"Theranostics"},{"key":"ref77","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12906-015-0940-9","article-title":"Isolation of a novel bio-peptide from walnut residual protein inducing apoptosis and autophagy on cancer cells","volume":"15","author":"Ma","year":"2015","journal-title":"BMC Complement Altern Med"},{"key":"ref78","unstructured":"Bloom AD. BG-4, a bioactive peptide from Momordica charantia, promotes apoptosis in ovarian cancer cells; 2018 [cited 2025 Feb 10]. Available from: https:\/\/trace.tennessee.edu\/cgi\/viewcontent.cgi?article=3196&context=utk_chanhonoproj."},{"key":"ref79","doi-asserted-by":"crossref","first-page":"4767","DOI":"10.1038\/onc.2013.422","article-title":"Novel role of Engrailed 1 as a prosurvival transcription factor in basal-like breast cancer and engineering of interference peptides block its oncogenic function","volume":"33","author":"Beltran","year":"2014","journal-title":"Oncogene"},{"key":"ref80","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S1567-5769(00)00017-5","article-title":"Induction of tumor necrosis factor-\u03b1 in solid tumor region by the orally administered synthetic muramyl dipeptide analogue, romurtide","volume":"1","author":"Ueda","year":"2001","journal-title":"Int Immunopharmacol"},{"key":"ref81","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1248\/cpb.52.1029","volume":"52","author":"Zhang","year":"2004","journal-title":"Chem Pharm Bull"},{"key":"ref82","first-page":"1934578X1300800326","volume":"8","author":"Kalinovskaya","year":"2013","journal-title":"Nat Prod Commun"},{"key":"ref83","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1046\/j.1365-2958.2003.03317.x","volume":"47","author":"Goto","year":"2003","journal-title":"Mol Microbiol"},{"key":"ref84","first-page":"343","article-title":"Anti-cancer peptides from bacteria","volume":"8","author":"Karpiaski","year":"2013","journal-title":"Bangladesh J Pharmacol"},{"key":"ref85","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1038\/ja.2007.31","volume":"60","author":"Matsuo","year":"2007","journal-title":"J Antibiot"},{"key":"ref86","author":"Karpi\u0144ski","year":"2012","journal-title":"New peptide (Entap) with anti-proliferative activity produced by bacteria of Enterococcus genus"},{"key":"ref87","doi-asserted-by":"crossref","first-page":"294","DOI":"10.3390\/toxins3030294","article-title":"Mechanism of diphtheria toxin catalytic domain delivery to the eukaryotic cell cytosol and the cellular factors that directly participate in the process","volume":"3","author":"Murphy","year":"2011","journal-title":"Toxins"},{"key":"ref88","first-page":"290","article-title":"Aktynomycyna D i mechanizmy jej dzia\u0142ania Actinomycin D and its mechanisms of action","volume":"59","author":"Koba","year":"2005","journal-title":"Postepy Hig Med Dosw (Online)"},{"key":"ref89","doi-asserted-by":"crossref","first-page":"5315","DOI":"10.1021\/bi400779r","article-title":"Characterization of bleomycin-mediated cleavage of a hairpin DNA library","volume":"52","author":"Segerman","year":"2013","journal-title":"Biochem"},{"key":"ref90","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.1099\/mic.0.062190-0","article-title":"Toxicity of bovicin HC5 against mammalian cell lines and the role of cholesterol in bacteriocin activity","volume":"158","author":"Paiva","year":"2012","journal-title":"Microbiol"},{"key":"ref91","doi-asserted-by":"crossref","first-page":"46541","DOI":"10.1038\/srep46541","article-title":"Anticancer properties of a defensin like class IId bacteriocin Laterosporulin10","volume":"7","author":"Baindara","year":"2017","journal-title":"Sci Rep"},{"key":"ref92","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1007\/s11274-010-0541-1","volume":"27","author":"Villarante","year":"2011","journal-title":"World J Microbiol Biotechnol"},{"key":"ref93","first-page":"4148","article-title":"Ability of the immunomodulating dipeptide bestatin to activate cytotoxic mononuclear phagocytes","volume":"43","author":"Schorlemmer","year":"1983","journal-title":"Cancer Res"},{"key":"ref94","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.canlet.2004.06.050","article-title":"Anti-tumor angiogenesis effect of aminopeptidase inhibitor bestatin against B16-BL6 melanoma cells orthotopically implanted into syngeneic mice","volume":"216","author":"Aozuka","year":"2004","journal-title":"Cancer Lett"},{"key":"ref95","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1002\/jsfa.7815","article-title":"Isolation and identification of anti-proliferative peptides from Spirulina platensis using three-step hydrolysis","volume":"97","author":"Wang","year":"2017","journal-title":"J Sci Food Agric"},{"key":"ref96","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1002\/btpr.1725","volume":"29","author":"Wang","year":"2013","journal-title":"Biotechnol Prog"},{"key":"ref97","doi-asserted-by":"crossref","first-page":"919","DOI":"10.3390\/ijms19030919","article-title":"Therapeutic properties and biological benefits of marine-derived anticancer peptides","volume":"19","author":"Kang","year":"2018","journal-title":"Int J Mol Sci"},{"key":"ref98","doi-asserted-by":"crossref","first-page":"258","DOI":"10.2174\/1871520614666140825112255","article-title":"Anticancer activity and mechanism investigation of beauvericin isolated from secondary metabolites of the mangrove endophytic fungi","volume":"15","author":"Tao","year":"2015","journal-title":"Anti-Cancer Agents Med Chem"},{"key":"ref99","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1475-2867-5-21","article-title":"Functional and structural characteristics of anticancer peptide Pep27 analogues","volume":"5","author":"Lee","year":"2005","journal-title":"Cancer Cell Int"},{"key":"ref100","doi-asserted-by":"crossref","first-page":"650","DOI":"10.7150\/ijbs.3897","article-title":"Selection of peptide inhibitor to matrix metalloproteinase-2 using phage display and its effects on pancreatic cancer cell lines PANC-1 and CFPAC-1","volume":"8","author":"Lu","year":"2012","journal-title":"Int J Biol Sci"},{"key":"ref101","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1073\/pnas.241655998","article-title":"Targeting the prostate for destruction through a vascular address","volume":"99","author":"Arap","year":"2002","journal-title":"Proc Natl Acad Sci"},{"key":"ref102","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s00280-009-1166-7","article-title":"The anti-cancer peptide, PNC-27, induces tumor cell lysis as the intact peptide","volume":"66","author":"Sookraj","year":"2010","journal-title":"Cancer Chemother Pharmacol"},{"key":"ref103","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s12282-007-0018-8","article-title":"Development of HER2-antagonistic peptides as novel anti-breast cancer drugs by in silico methods","volume":"15","author":"Nakajima","year":"2008","journal-title":"Breast Cancer"},{"key":"ref104","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/nm720","article-title":"A tumor-homing peptide with a targeting specificity related to lymphatic vessels","volume":"8","author":"Laakkonen","year":"2002","journal-title":"Nat Med"},{"key":"ref105","doi-asserted-by":"crossref","first-page":"5371","DOI":"10.1158\/0008-5472.CAN-05-4569","article-title":"Inhibition of tumor growth and elimination of multiple metastases in human prostate and breast xenografts by systemic inoculation of a host defense-like lytic peptide","volume":"66","author":"Papo","year":"2006","journal-title":"Cancer Res"},{"key":"ref106","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.abb.2012.02.017","article-title":"Screening of integrin-binding peptides from the laminin \u03b14 and \u03b15 chain G domain peptide library","volume":"521","author":"Katagiri","year":"2012","journal-title":"Arch Biochem Biophys"},{"key":"ref107","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1021\/acs.nanolett.6b03815","article-title":"Tumor-penetrating nanosystem strongly suppresses breast tumor growth","volume":"17","author":"Sharma","year":"2017","journal-title":"Nano Lett"},{"key":"ref108","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1158\/1541-7786.MCR-06-0069","volume":"5","author":"Lee","year":"2007","journal-title":"Mol Cancer"},{"key":"ref109","first-page":"309","article-title":"Anti-invasive, antitumorigenic, and antimetastatic activities of the PHSCN sequence in prostate carcinoma","volume":"60","author":"Livant","year":"2000","journal-title":"Cancer Res"},{"key":"ref110","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.jconrel.2008.07.024","article-title":"Specific targeting of the vasculature of gastric cancer by a new tumor-homing peptide CGNSNPKSC","volume":"131","author":"Hui","year":"2008","journal-title":"J Controlled Release"},{"key":"ref111","doi-asserted-by":"crossref","first-page":"559","DOI":"10.4103\/1735-5362.327503","article-title":"Anti-angiogenic peptides application in cancer therapy; a review","volume":"16","author":"Shoari","year":"2021","journal-title":"Res Pharm Sci"},{"key":"ref112","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1038\/onc.2010.9","volume":"29","author":"Nasarre","year":"2010","journal-title":"Oncogene"},{"key":"ref113","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1038\/s12276-023-01016-x","article-title":"Peptides as multifunctional players in cancer therapy","volume":"55","author":"Vadevoo","year":"2023","journal-title":"Exp Mol Med"},{"key":"ref114","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/s41467-023-43346-4","volume":"15","author":"Chandramohan","year":"2024","journal-title":"Nat Commun"},{"key":"ref115","doi-asserted-by":"crossref","first-page":"E3445","DOI":"10.1073\/pnas.1303002110","article-title":"Stapled \u03b1\u2212helical peptide drug development: a potent dual inhibitor of MDM2 and MDMX for p53-dependent cancer therapy","volume":"110","author":"Chang","year":"2013","journal-title":"Proc Natl Acad Sci"},{"key":"ref116","doi-asserted-by":"crossref","first-page":"44","DOI":"10.4161\/jkst.18947","article-title":"A membrane penetrating peptide aptamer inhibits STAT3 function and suppresses the growth of STAT3 addicted tumor cells","volume":"1","author":"Borghouts","year":"2012","journal-title":"JAK-STAT"},{"key":"ref117","doi-asserted-by":"crossref","first-page":"154","DOI":"10.37349\/eds.2024.00041","article-title":"Stapled peptides: targeting protein-protein interactions in drug development","volume":"2","author":"Zhang","year":"2024","journal-title":"Explor Drug Sci"},{"key":"ref118","doi-asserted-by":"crossref","first-page":"107842","DOI":"10.1016\/j.bioelechem.2021.107842","article-title":"Interaction of LL-37 human cathelicidin peptide with a model microbial-like lipid membrane","volume":"141","author":"Majewska","year":"2021","journal-title":"Bioelectrochem"},{"key":"ref119","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s12645-021-00085-9","volume":"12","author":"Dabbagh Moghaddam","year":"2021","journal-title":"Cancer Nanotechnol"},{"key":"ref120","doi-asserted-by":"crossref","first-page":"e6800","DOI":"10.1002\/cam4.6800","article-title":"RGD peptide in cancer targeting: benefits, challenges, solutions, and possible integrin-RGD interactions","volume":"13","author":"Javid","year":"2024","journal-title":"Cancer Med"},{"key":"ref121","doi-asserted-by":"crossref","first-page":"9367845","DOI":"10.1155\/2019\/9367845","article-title":"iRGD: a promising peptide for cancer imaging and a potential therapeutic agent for various cancers","volume":"2019","author":"Zuo","year":"2019","journal-title":"J Oncol"},{"key":"ref122","first-page":"1","article-title":"Modelling the impact of nucleolin expression level on the activity of F3 peptide-targeted pH-sensitive pegylated liposomes containing doxorubicin","volume":"2022","author":"Lopes","year":"2022","journal-title":"Drug Deliv Transl Res"},{"key":"ref123","doi-asserted-by":"crossref","first-page":"5046","DOI":"10.1021\/acs.molpharmaceut.8b00647","article-title":"Human serum albumin and the p53-derived peptide fusion protein promotes cytotoxicity irrespective of p53 status in cancer cells","volume":"15","author":"Roscoe","year":"2018","journal-title":"Mol Pharm"},{"key":"ref124","doi-asserted-by":"crossref","first-page":"6064","DOI":"10.1038\/srep06064","article-title":"Multifunctional enveloped mesoporous silica nanoparticles for subcellular co-delivery of drug and therapeutic peptide","volume":"4","author":"Luo","year":"2014","journal-title":"Sci Rep"},{"key":"ref125","doi-asserted-by":"crossref","first-page":"853","DOI":"10.2174\/1389203724666230822100131","article-title":"BH3 mimetic peptides: an effective strategy to complement anticancer therapy","volume":"24","author":"Saraswathy","year":"2023","journal-title":"Curr Protein Pept Sci"},{"key":"ref126","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.ijpharm.2016.08.048","article-title":"Discovery of PSMA-specific peptide ligands for targeted drug delivery","volume":"513","author":"Jin","year":"2016","journal-title":"Int J Pharm"},{"key":"ref127","doi-asserted-by":"crossref","first-page":"9434","DOI":"10.1021\/bi060264j","article-title":"Targeting heat shock proteins on cancer cells: selection, characterization, and cell-penetrating properties of a peptidic GRP78 ligand","volume":"45","author":"Kim","year":"2006","journal-title":"Biochem"},{"key":"ref128","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1093\/annonc\/mdm140","article-title":"Assessment of the biological and pharmacological effects of the \u03b1\u03bd\u03b23 and \u03b1\u03bd\u03b25 integrin receptor antagonist, cilengitide (EMD 121974), in patients with advanced solid tumors","volume":"18","author":"Hariharan","year":"2007","journal-title":"Ann Oncol"},{"key":"ref129","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1073\/pnas.251687998","article-title":"Molecular specialization of breast vasculature: a breast-homing phage-displayed peptide binds to aminopeptidase P in breast vasculature","volume":"99","author":"Essler","year":"2002","journal-title":"Proc Natl Acad Sci"},{"key":"ref130","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1158\/1541-7786.MCR-08-0538","volume":"7","author":"Mueller","year":"2009","journal-title":"Mol Cancer Res"},{"key":"ref131","doi-asserted-by":"crossref","first-page":"a041046","DOI":"10.1101\/cshperspect.a041046","article-title":"The mitochondrial pathway of apoptosis part II: the BCL-2 protein family","volume":"14","author":"Green","year":"2022","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"ref132","doi-asserted-by":"crossref","first-page":"944","DOI":"10.3390\/ijms26030944","article-title":"Elamipretide: a review of its structure, mechanism of action, and therapeutic potential","volume":"26","author":"Tung","year":"2025","journal-title":"Int J Mol Sci"},{"key":"ref133","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.ajpath.2010.11.014","article-title":"Mitochondrial apoptosis-induced channel (MAC) function triggers a Bax\/Bak-dependent bystander effect","volume":"178","author":"Peixoto","year":"2011","journal-title":"Am J Pathol"},{"key":"ref134","doi-asserted-by":"crossref","first-page":"1307860","DOI":"10.3389\/fphar.2023.1307860","article-title":"Recent advances of anti-angiogenic inhibitors targeting VEGF\/VEGFR axis","volume":"14","author":"Wang","year":"2024","journal-title":"Front Pharmacol"},{"key":"ref135","doi-asserted-by":"crossref","first-page":"46681","DOI":"10.1074\/jbc.M308681200","article-title":"A vascular endothelial growth factor high affinity receptor 1-specific peptide with antiangiogenic activity identified using a phage display peptide library","volume":"278","author":"El-Mousawi","year":"2003","journal-title":"J Biol Chem"},{"key":"ref136","first-page":"595","article-title":"The functions and applications of A7R in anti-angiogenic therapy, imaging and drug delivery systems","volume":"14","author":"Lu","year":"2019","journal-title":"Asian J Pharm Sci"},{"key":"ref137","doi-asserted-by":"crossref","first-page":"5014","DOI":"10.1091\/mbc.e07-01-0004","article-title":"Transactivation of vascular endothelial growth factor receptor-2 by interleukin-8 (IL-8\/CXCL8) is required for IL-8\/CXCL8-induced endothelial permeability","volume":"18","author":"Petreaca","year":"2007","journal-title":"Mol Biol Cell"},{"key":"ref138","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/B978-0-12-815762-6.00002-0","article-title":"Physiology of cellular demise: apoptosis, necrosis, and autophagy","volume":"14","author":"Kaur","year":"2021","journal-title":"Clin Perspect Target Ther Apopt: Elsevier"},{"key":"ref139","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/sj.neo.7900203","article-title":"TRAIL\/Apo-2L: mechanisms and clinical applications in cancer","volume":"3","author":"Srivastava","year":"2001","journal-title":"Neoplasia"},{"key":"ref140","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/978-3-031-62007-2_11","article-title":"Fusion proteins: current status and future perspectives","author":"Schmidt","year":"2024","journal-title":"Bioprocessing, bioengineering and process chemistry in the biopharmaceutical industry: using chemistry and bioengineering to improve the performance of biologics"},{"key":"ref141","doi-asserted-by":"crossref","first-page":"3718","DOI":"10.1172\/JCI61931","article-title":"Suppressing T cell motility induced by anti-CTLA-4 monotherapy improves antitumor effects","volume":"122","author":"Ruocco","year":"2012","journal-title":"J Clin Invest"},{"key":"ref142","author":"Lischer","year":"2023","journal-title":"Computational methods to find and rank MHC-I restricted tumor-associated antigens to improve therapeutic efficacy and tolerability of antigen-based cancer immunotherapy"},{"key":"ref143","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/bs.apcsb.2016.10.002","article-title":"The functional stability of FOXP3 and ROR\u03b3t in Treg and Th17 and their therapeutic applications","volume":"107","author":"Ren","year":"2017","journal-title":"Adv Protein Chem Struct Biol"},{"key":"ref144","first-page":"188881","article-title":"Advances in nuclei targeted delivery of nanoparticles for the management of cancer","volume":"1878","author":"Goyal","year":"2023","journal-title":"BBA Rev Cancer"},{"key":"ref145","doi-asserted-by":"crossref","first-page":"797","DOI":"10.3390\/biology12060797","article-title":"New perspectives on the role of nuclear proteases in cell death pathways","volume":"12","author":"Frolova","year":"2023","journal-title":"Biol"},{"key":"ref146","author":"Herman","year":"2015","journal-title":"Investigation of the molecular mechanisms and therapeutic potential of oncogene-induced kinetochore-microtubule defects"},{"key":"ref147","doi-asserted-by":"crossref","first-page":"34910","DOI":"10.18632\/oncotarget.5308","article-title":"The oncolytic peptide LTX-315 induces cell death and DAMP release by mitochondria distortion in human melanoma cells","volume":"6","author":"Eike","year":"2015","journal-title":"Oncotarget"},{"key":"ref148","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1021\/acs.jmedchem.9b01694","article-title":"Novel cell-penetrating peptide conjugated proteasome inhibitors: anticancer and antifungal investigations","volume":"63","author":"Patel","year":"2019","journal-title":"J Med Chem"},{"key":"ref149","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.tranon.2019.10.001","article-title":"Targeting tumor microenvironment by small-molecule inhibitors","volume":"13","author":"Zhong","year":"2020","journal-title":"Transl Oncol"},{"key":"ref150","doi-asserted-by":"crossref","first-page":"541","DOI":"10.3390\/cells10030541","article-title":"Targeting the hypoxic and acidic tumor microenvironment with pH-sensitive peptides","volume":"10","author":"Dharmaratne","year":"2021","journal-title":"Cells"},{"key":"ref151","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/s41392-021-00544-0","article-title":"Extracellular matrix and its therapeutic potential for cancer treatment","volume":"6","author":"Huang","year":"2021","journal-title":"Signal Transduct Target Ther"},{"key":"ref152","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/s41573-020-0090-8","article-title":"Engineering precision nanoparticles for drug delivery","volume":"20","author":"Mitchell","year":"2021","journal-title":"Nat Rev Drug Discov"},{"key":"ref153","doi-asserted-by":"crossref","first-page":"3768","DOI":"10.3390\/cancers16223768","article-title":"Enhancing tumor targeted therapy: the role of iRGD peptide in advanced drug delivery systems","volume":"16","author":"Nikitovic","year":"2024","journal-title":"Cancers"},{"key":"ref154","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.jconrel.2021.11.024","article-title":"Engineered strategies to enhance tumor penetration of drug-loaded nanoparticles","volume":"341","author":"Souri","year":"2022","journal-title":"J Control Release"},{"key":"ref155","doi-asserted-by":"crossref","first-page":"118","DOI":"10.3390\/biom12010118","article-title":"Melittin-based nano-delivery systems for cancer therapy","volume":"12","author":"Wang","year":"2022","journal-title":"Biomolecules"},{"key":"ref156","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.jconrel.2020.09.055","article-title":"Peptide-functionalized liposomes as therapeutic and diagnostic tools for cancer treatment","volume":"329","author":"Sonju","year":"2021","journal-title":"J Control Release"},{"key":"ref157","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.3390\/molecules27041372","article-title":"A review of liposomes as a drug delivery system: current status of approved products, regulatory environments, and future perspectives","volume":"27","author":"Liu","year":"2022","journal-title":"Molecules"},{"key":"ref158","doi-asserted-by":"crossref","first-page":"153","DOI":"10.22270\/jddt.v14i10.6802","article-title":"Synthetic and natural polymers enhancing drug delivery and their treatment: a comprehensive review","volume":"14","author":"Saini","year":"2024","journal-title":"J Drug Deliv Ther"},{"key":"ref159","doi-asserted-by":"crossref","first-page":"843","DOI":"10.3390\/polym16060843","article-title":"Polymer-based drug delivery systems for cancer therapeutics","volume":"16","author":"Ding","year":"2024","journal-title":"Polym"},{"key":"ref160","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.3390\/pharmaceutics15082102","article-title":"Pluronic F-68 and F-127 based nanomedicines for advancing combination cancer therapy","volume":"15","author":"Khaliq","year":"2023","journal-title":"Pharmaceutics"},{"key":"ref161","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1021\/acs.oprd.6b00374","article-title":"Patent review of manufacturing routes to oncology drugs: carfilzomib, osimertinib, and venetoclax","volume":"20","author":"Hughes","year":"2016","journal-title":"Org Process Res Dev"},{"key":"ref162","doi-asserted-by":"crossref","first-page":"e000650","DOI":"10.1136\/esmoopen-2019-000650","article-title":"Safety, tolerability and clinical implementation of \u2018ready-to-use\u2019 68gallium-DOTA0-Tyr3-octreotide (68Ga-DOTATOC)(SomaKIT TOC) for injection in patients diagnosed with gastroenteropancreatic neuroendocrine tumours (GEP-NETs)","volume":"5","author":"Manoharan","year":"2020","journal-title":"ESMO Open"},{"key":"ref163","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1007\/s40265-016-0596-x","article-title":"Venetoclax: first global approval","volume":"76","author":"Deeks","year":"2016","journal-title":"Drugs"},{"key":"ref164","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s40265-015-0533-4","article-title":"Osimertinib: first global approval","volume":"76","author":"Greig","year":"2016","journal-title":"Drugs"},{"key":"ref165","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1186\/s12951-024-02901-x","article-title":"Nanotechnology in healthcare, and its safety and environmental risks","volume":"22","author":"Ma","year":"2024","journal-title":"J Nanobiotechnol"},{"key":"ref166","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12885-017-3194-8","article-title":"Aprepitant for refractory cutaneous T-cell lymphoma-associated pruritus: 4 cases and a review of the literature","volume":"17","author":"Song","year":"2017","journal-title":"BMC Cancer"},{"key":"ref167","doi-asserted-by":"crossref","first-page":"e10608","DOI":"10.1016\/j.heliyon.2022.e10608","article-title":"Cisplatin for cancer therapy and overcoming chemoresistance","volume":"8","author":"Ranasinghe","year":"2022","journal-title":"Heliyon"},{"key":"ref168","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1056\/NEJMoa2028485","article-title":"Sacituzumab govitecan in metastatic triple-negative breast cancer","volume":"384","author":"Bardia","year":"2021","journal-title":"New England J Med"},{"key":"ref169","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1056\/NEJMoa2107322","article-title":"Lutetium-177-PSMA-617 for metastatic castration-resistant prostate cancer","volume":"385","author":"Sartor","year":"2021","journal-title":"New England J Med"},{"key":"ref170","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1200\/JCO.2001.19.2.376","article-title":"Pivotal phase III trial of two dose levels of denileukin diftitox for the treatment of cutaneous T-cell lymphoma","volume":"19","author":"Olsen","year":"2001","journal-title":"J Clin Oncol"},{"key":"ref171","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/S1470-2045(16)30565-4","article-title":"Rovalpituzumab tesirine, a DLL3-targeted antibody-drug conjugate, in recurrent small-cell lung cancer: a first-in-human, first-in-class, open-label, phase 1 study","volume":"18","author":"Rudin","year":"2017","journal-title":"Lancet Oncol"},{"key":"ref172","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S1470-2045(15)70127-0","article-title":"Ramucirumab versus placebo in combination with second-line FOLFIRI in patients with metastatic colorectal carcinoma that progressed during or after first-line therapy with bevacizumab, oxaliplatin, and a fluoropyrimidine (RAISE): a randomised, double-blind, multicentre, phase 3 study","volume":"16","author":"Tabernero","year":"2015","journal-title":"Lancet Oncol"},{"key":"ref173","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/s41592-022-01488-1","article-title":"ColabFold: making protein folding accessible to all","volume":"19","author":"Mirdita","year":"2022","journal-title":"Nat Met"},{"key":"ref174","doi-asserted-by":"crossref","first-page":"W296","DOI":"10.1093\/nar\/gky427","article-title":"SWISS-MODEL: homology modelling of protein structures and complexes","volume":"46","author":"Waterhouse","year":"2018","journal-title":"Nucleic Acids Res"},{"key":"ref175","doi-asserted-by":"crossref","first-page":"843","DOI":"10.62940\/als.v11i4.3142","article-title":"Bioinformatic analysis of oxygen sensitivity in Alorcobacter bivalviorum\u2019s pyruvate: ferredoxin oxidoreductase (PFOR)","volume":"11","author":"Alqurashi","year":"2024","journal-title":"Adv Life Sci"},{"key":"ref176","doi-asserted-by":"crossref","first-page":"1501010","DOI":"10.3389\/fcimb.2024.1501010","article-title":"Computational biology and artificial intelligence in mRNA vaccine design for cancer immunotherapy","volume":"14","author":"Imani","year":"2025","journal-title":"Front Cell Infect Microbiol"},{"key":"ref177","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/B978-0-443-18638-7.00017-7","article-title":"Tools and software for computer-aided drug design and discovery","author":"Yang","year":"2023","journal-title":"Cheminformatics, QSAR and machine learning applications for novel drug development"},{"key":"ref178","doi-asserted-by":"crossref","first-page":"5634","DOI":"10.1038\/s41596-021-00628-9","article-title":"The trRosetta server for fast and accurate protein structure prediction","volume":"16","author":"Du","year":"2021","journal-title":"Nat Prot"},{"key":"ref179","unstructured":"Laskowski R, MacArthur M, Thornton J. PROCHECK: validation of protein-structure coordinates; 2006 [cited 2025 Feb 10]. Available from: https:\/\/onlinelibrary.wiley.com\/iucr\/itc\/Fa\/ch25o2v0001\/sec25o2o6\/."},{"key":"ref180","doi-asserted-by":"crossref","first-page":"604","DOI":"10.62940\/als.v10i4.2239","article-title":"Identification of potential inhibitors targeting DNA adenine methyltransferase of Klebsiella pneumoniae for antimicrobial resistance management: a structure-based molecular docking study","volume":"10","author":"Alshehri","year":"2024","journal-title":"Adv Life Sci"},{"key":"ref181","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1107\/S0907444909042073","article-title":"MolProbity: all-atom structure validation for macromolecular crystallography","volume":"66","author":"Chen","year":"2010","journal-title":"Acta Crystallographica Section D: Biol Crystal"},{"key":"ref182","doi-asserted-by":"crossref","first-page":"W510","DOI":"10.1093\/nar\/gkp322","article-title":"QMEAN server for protein model quality estimation","volume":"37","author":"Benkert","year":"2009","journal-title":"Nucleic Acids Res"},{"key":"ref183","doi-asserted-by":"crossref","first-page":"412","DOI":"10.62940\/als.v8i4.1297","article-title":"In silico analysis to reveal underlying trans differentiation mechanism of mesenchymal stem cells into osteocytes","volume":"8","author":"Javaid","year":"2021","journal-title":"Adv Life Sci"},{"key":"ref184","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/S0076-6879(97)77022-8","author":"Eisenberg","year":"1997","journal-title":"Methods in Enzymology"},{"key":"ref185","article-title":"Improved docking of protein models by a combination of Alphafold2 and ClusPro","author":"Ghani","year":"2021","journal-title":"BioRxiv"},{"key":"ref186","doi-asserted-by":"crossref","first-page":"3219","DOI":"10.1038\/s41596-024-01011-0","article-title":"The HADDOCK2. 4 web server for integrative modeling of biomolecular complexes","volume":"19","author":"Honorato","year":"2024","journal-title":"Nat Protoc"},{"key":"ref187","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/11779322231182560","article-title":"In silico investigation of a chimeric IL24-LK6 fusion protein as a potent candidate against breast cancer","volume":"17","author":"Muhammad Rehman","year":"2023","journal-title":"Bioinform Biol Insights"},{"key":"ref188","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1093\/bioinformatics\/btu097","article-title":"ZDOCK server: interactive docking prediction of protein-protein complexes and symmetric multimers","volume":"30","author":"Pierce","year":"2014","journal-title":"Bioinform"},{"key":"ref189","doi-asserted-by":"crossref","first-page":"912","DOI":"10.62940\/als.v11i4.3514","article-title":"In-vitro and in-silico studies based discovery of 2-aryl-N-(4-morpholinophenyl) thiazol-4-amines as promising DNA gyrase inhibitors","volume":"11","author":"Imran","year":"2024","journal-title":"Adv Life Sci"},{"key":"ref190","doi-asserted-by":"crossref","unstructured":"Mursal M, Ahmad M, Hussain S, Khan MF. Navigating the computational seas: a comprehensive overview of molecular docking software in drug discovery. 2024. doi:10.5772\/intechopen.1004802.","DOI":"10.5772\/intechopen.1004802"},{"key":"ref191","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1002\/jcc.20084","article-title":"UCSF Chimera\u2014a visualization system for exploratory research and analysis","volume":"25","author":"Pettersen","year":"2004","journal-title":"J Comput Chem"},{"key":"ref192","doi-asserted-by":"crossref","first-page":"36","DOI":"10.62940\/als.v9i1.1056","article-title":"Computational prediction of Cassia angustifolia compounds as a potential drug agents against main protease of SARS-nCov2","volume":"9","author":"Saif","year":"2022","journal-title":"Adv Life Sci"},{"key":"ref193","article-title":"Breaking down the parallel performance of gromacs, a high-performance molecular dynamics software","author":"Andersson","year":"2022","journal-title":"International Conference on Parallel Processing and Applied Mathematics"},{"key":"ref194","first-page":"4983","article-title":"Py-MCMD: python software for performing hybrid Monte Carlo\/molecular dynamics simulations with GOMC and NAMD","volume":"18","author":"Barhaghi","year":"2022","journal-title":"J Chem The Comput"},{"key":"ref195","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1002\/jcc.20035","article-title":"Development and testing of a general amber force field","volume":"25","author":"Wang","year":"2004","journal-title":"J Computat Chem"},{"key":"ref196","doi-asserted-by":"crossref","first-page":"878","DOI":"10.62940\/als.v11i4.3308","article-title":"In-silico perspectives on the potential therapeutic aids of hesperetin derivatives for lung cancer","volume":"11","author":"Asiri","year":"2024","journal-title":"Adv Life Sci"},{"key":"ref197","doi-asserted-by":"crossref","first-page":"tfae179","DOI":"10.1093\/toxres\/tfae179","article-title":"Design and computational analysis of a novel Azurin-BR2 chimeric protein against breast cancer","volume":"13","author":"Rehman","year":"2024","journal-title":"Toxicol Res"},{"key":"ref198","doi-asserted-by":"crossref","first-page":"tfae174","DOI":"10.1093\/toxres\/tfae174","article-title":"Design and computational analysis of a novel Leptulipin-p28 fusion protein as a multitarget anticancer therapy in breast cancer","volume":"13","author":"Khalid","year":"2024","journal-title":"Toxicol Res"},{"key":"ref199","doi-asserted-by":"crossref","first-page":"3223","DOI":"10.17576\/jsm-2023-5211-15","article-title":"In silico Design and Evaluation of Novel Cell Targeting Melittin-Interleukin-24 Fusion Protein: a Potential Drug Candidate Against Breast Cancer","volume":"52","author":"Rehman","year":"2023","journal-title":"Sains Malaysiana"},{"key":"ref200","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.3390\/pharmaceutics15071825","volume":"15","author":"Aslam","year":"2023","journal-title":"Pharmaceutics"},{"key":"ref201","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1007\/s40203-024-00252-x","article-title":"Investigation of therapeutic potential of the Il24-p20 fusion protein against breast cancer: an in-silico approach","volume":"12","author":"Qureshi","year":"2024","journal-title":"Silico Pharmacol"},{"key":"ref202","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s13568-024-01747-8","article-title":"Computational modeling study of IL-15-NGR peptide fusion protein: a targeted therapeutics for hepatocellular carcinoma","volume":"14","author":"Fatima","year":"2024","journal-title":"AMB Exp"},{"key":"ref203","first-page":"3449","article-title":"A comprehensive in silico study of the NDB-IL-24 fusion protein for tumor targeting: a promising anti-cancer therapeutic candidate","volume":"38","author":"Hafiz Muhammad","year":"2024","journal-title":"J Bio Reg Home Agents"},{"key":"ref204","doi-asserted-by":"crossref","first-page":"305","DOI":"10.30699\/IJP.2019.101200.2004","article-title":"Designing and analyzing the structure of DT-STXB fusion protein as an anti-tumor agent: an in silico approach","volume":"14","author":"Moghadam","year":"2019","journal-title":"Iranian J Pathol"},{"key":"ref205","first-page":"e83315","article-title":"In silico evaluation of two targeted chimeric proteins based on bacterial toxins for breast cancer therapy","volume":"12","author":"Goleij","year":"2019","journal-title":"Int J Cancer Manag"}],"container-title":["Oncology Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/cdn.techscience.cn\/files\/or\/2025\/TSP_OR-33-7\/OncolRes-33-07-62197\/OncolRes-33-62197.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T01:40:09Z","timestamp":1763343609000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.techscience.com\/or\/v33n7\/62636"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":205,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2025]]},"published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.32604\/or.2025.062197","relation":{},"ISSN":["1555-3906"],"issn-type":[{"value":"1555-3906","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025]]}}}